Search

We introduce SAGE; a Generative LLM for inferring attribute values for products across world-wide e-Commerce catalogs. We introduce a novel formulation of the attribute-value prediction problem as a Seq2Seq summarization task, across languages, product types and target attributes. Our novel modeling approach lifts the restriction of predicting attribute values within a pre-specified set of choices, as well as, the requirement that the sought attribute values need to be explicitly mentioned in the text. SAGE can infer attribute values even when such values are mentioned implicitly using periphrastic language, or not-at-all-as is the case for common-sense defaults. Additionally, SAGE is capable of predicting whether an attribute is inapplicable for the product at hand, or non-obtainable from the available information. SAGE is the first method able to tackle all aspects of the attribute-value-prediction task as they arise in practical settings in e-Commerce catalogs. A comprehensive set of experiments demonstrates the effectiveness of the proposed approach, as well as, its superiority against state-of-the-art competing alternatives. Moreover, our experiments highlight SAGE's ability to tackle the task of predicting attribute values in zero-shot setting; thereby, opening up opportunities for significantly reducing the overall number of labeled examples required for training., Comment: (17 pages)

Federated Learning (FL) is a distributed machine learning approach that safeguards privacy by creating an impartial global model while respecting the privacy of individual client data. However, the conventional FL method can introduce security risks when dealing with diverse client data, potentially compromising privacy and data integrity. To address these challenges, we present a differential privacy (DP) federated deep learning framework in medical image segmentation. In this paper, we extend our similarity weight aggregation (SimAgg) method to DP-SimAgg algorithm, a differentially private similarity-weighted aggregation algorithm for brain tumor segmentation in multi-modal magnetic resonance imaging (MRI). Our DP-SimAgg method not only enhances model segmentation capabilities but also provides an additional layer of privacy preservation. Extensive benchmarking and evaluation of our framework, with computational performance as a key consideration, demonstrate that DP-SimAgg enables accurate and robust brain tumor segmentation while minimizing communication costs during model training. This advancement is crucial for preserving the privacy of medical image data and safeguarding sensitive information. In conclusion, adding a differential privacy layer in the global weight aggregation phase of the federated brain tumor segmentation provides a promising solution to privacy concerns without compromising segmentation model efficacy. By leveraging DP, we ensure the protection of client data against adversarial attacks and malicious participants.

In federated learning (FL), the global model at the server requires an efficient mechanism for weight aggregation and a systematic strategy for collaboration selection to manage and optimize communication payload. We introduce a practical and cost-efficient method for regularized weight aggregation and propose a laborsaving technique to select collaborators per round. We illustrate the performance of our method, regularized similarity weight aggregation (RegSimAgg), on the Federated Tumor Segmentation (FeTS) 2022 challenge's federated training (weight aggregation) problem. Our scalable approach is principled, frugal, and suitable for heterogeneous non-IID collaborators. Using FeTS2021 evaluation criterion, our proposed algorithm RegSimAgg stands at 3rd position in the final rankings of FeTS2022 challenge in the weight aggregation task. Our solution is open sourced at: \url{https://github.com/dskhanirfan/FeTS2022}

The number of international benchmarking competitions is steadily increasing in various fields of machine learning (ML) research and practice. So far, however, little is known about the common practice as well as bottlenecks faced by the community in tackling the research questions posed. To shed light on the status quo of algorithm development in the specific field of biomedical imaging analysis, we designed an international survey that was issued to all participants of challenges conducted in conjunction with the IEEE ISBI 2021 and MICCAI 2021 conferences (80 competitions in total). The survey covered participants' expertise and working environments, their chosen strategies, as well as algorithm characteristics. A median of 72% challenge participants took part in the survey. According to our results, knowledge exchange was the primary incentive (70%) for participation, while the reception of prize money played only a minor role (16%). While a median of 80 working hours was spent on method development, a large portion of participants stated that they did not have enough time for method development (32%). 25% perceived the infrastructure to be a bottleneck. Overall, 94% of all solutions were deep learning-based. Of these, 84% were based on standard architectures. 43% of the respondents reported that the data samples (e.g., images) were too large to be processed at once. This was most commonly addressed by patch-based training (69%), downsampling (37%), and solving 3D analysis tasks as a series of 2D tasks. K-fold cross-validation on the training set was performed by only 37% of the participants and only 50% of the participants performed ensembling based on multiple identical models (61%) or heterogeneous models (39%). 48% of the respondents applied postprocessing steps.

We investigate the generalizability of deep convolutional neural network (CNN) on the task of disease classification from chest x-rays collected over multiple sites. We systematically train the model using datasets from three independent sites with different patient populations: National Institute of Health (NIH), Stanford University Medical Centre (CheXpert), and Shifa International Hospital (SIH). We formulate a sequential training approach and demonstrate that the model produces generalized prediction performance using held out test sets from the three sites. Our model generalizes better when trained on multiple datasets, with the CheXpert-Shifa-NET model performing significantly better (p-values < 0.05) than the models trained on individual datasets for 3 out of the 4 distinct disease classes. The code for training the model will be made available open source at: www.github.com/link-to-code at the time of publication.

We introduce the federated multi-view matrix factorization method that extends the federated learning framework to matrix factorization with multiple data sources. Our method is able to learn the multi-view model without transferring the user's personal data to a central server. As far as we are aware this is the first federated model to provide recommendations using multi-view matrix factorization. The model is rigorously evaluated on three datasets on production settings. Empirical validation confirms that federated multi-view matrix factorization outperforms simpler methods that do not take into account the multi-view structure of the data, in addition, it demonstrates the usefulness of the proposed method for the challenging prediction tasks of cold-start federated recommendations., Comment: 16 pages, 3 figures, 5 tables, submitted to a conference

The increasing interest in user privacy is leading to new privacy preserving machine learning paradigms. In the Federated Learning paradigm, a master machine learning model is distributed to user clients, the clients use their locally stored data and model for both inference and calculating model updates. The model updates are sent back and aggregated on the server to update the master model then redistributed to the clients. In this paradigm, the user data never leaves the client, greatly enhancing the user' privacy, in contrast to the traditional paradigm of collecting, storing and processing user data on a backend server beyond the user's control. In this paper we introduce, as far as we are aware, the first federated implementation of a Collaborative Filter. The federated updates to the model are based on a stochastic gradient approach. As a classical case study in machine learning, we explore a personalized recommendation system based on users' implicit feedback and demonstrate the method's applicability to both the MovieLens and an in-house dataset. Empirical validation confirms a collaborative filter can be federated without a loss of accuracy compared to a standard implementation, hence enhancing the user's privacy in a widely used recommender application while maintaining recommender performance., Comment: 12 pages, 2 figures, 2 tables, submitted to a conference

A key goal of computational personalized medicine is to systematically utilize genomic and other molecular features of samples to predict drug responses for a previously unseen sample. Such predictions are valuable for developing hypotheses for selecting therapies tailored for individual patients. This is especially valuable in oncology, where molecular and genetic heterogeneity of the cells has a major impact on the response. However, the prediction task is extremely challenging, raising the need for methods that can effectively model and predict drug responses. In this study, we propose a novel formulation of multi-task matrix factorization that allows selective data integration for predicting drug responses. To solve the modeling task, we extend the state-of-the-art kernelized Bayesian matrix factorization (KBMF) method with component-wise multiple kernel learning. In addition, our approach exploits the known pathway information in a novel and biologically meaningful fashion to learn the drug response associations. Our method quantitatively outperforms the state of the art on predicting drug responses in two publicly available cancer data sets as well as on a synthetic data set. In addition, we validated our model predictions with lab experiments using an in-house cancer cell line panel. We finally show the practical applicability of the proposed method by utilizing prior knowledge to infer pathway-drug response associations, opening up the opportunity for elucidating drug action mechanisms. We demonstrate that pathway-response associations can be learned by the proposed model for the well known EGFR and MEK inhibitors., Comment: Accepted in European Conference in Computational Biology, to be published in Bioinformatics 2016

We propose the convex factorization machine (CFM), which is a convex variant of the widely used Factorization Machines (FMs). Specifically, we employ a linear+quadratic model and regularize the linear term with the $\ell_2$-regularizer and the quadratic term with the trace norm regularizer. Then, we formulate the CFM optimization as a semidefinite programming problem and propose an efficient optimization procedure with Hazan's algorithm. A key advantage of CFM over existing FMs is that it can find a globally optimal solution, while FMs may get a poor locally optimal solution since the objective function of FMs is non-convex. In addition, the proposed algorithm is simple yet effective and can be implemented easily. Finally, CFM is a general factorization method and can also be used for other factorization problems including including multi-view matrix factorization and tensor completion problems. Through synthetic and movielens datasets, we first show that the proposed CFM achieves results competitive to FMs. Furthermore, in a toxicogenomics prediction task, we show that CFM outperforms a state-of-the-art tensor factorization method.

We introduce Bayesian multi-tensor factorization, a model that is the first Bayesian formulation for joint factorization of multiple matrices and tensors. The research problem generalizes the joint matrix-tensor factorization problem to arbitrary sets of tensors of any depth, including matrices, can be interpreted as unsupervised multi-view learning from multiple data tensors, and can be generalized to relax the usual trilinear tensor factorization assumptions. The result is a factorization of the set of tensors into factors shared by any subsets of the tensors, and factors private to individual tensors. We demonstrate the performance against existing baselines in multiple tensor factorization tasks in structural toxicogenomics and functional neuroimaging., Comment: R Implementation / source code: http://research.cs.aalto.fi/pml/software/mtf/

Motivation: Analysis of relationships of drug structure to biological response is key to understanding off-target and unexpected drug effects, and for developing hypotheses on how to tailor drug thera-pies. New methods are required for integrated analyses of a large number of chemical features of drugs against the corresponding genome-wide responses of multiple cell models. Results: In this paper, we present the first comprehensive multi-set analysis on how the chemical structure of drugs impacts on ge-nome-wide gene expression across several cancer cell lines (CMap database). The task is formulated as searching for drug response components across multiple cancers to reveal shared effects of drugs and the chemical features that may be responsible. The com-ponents can be computed with an extension of a very recent ap-proach called Group Factor Analysis (GFA). We identify 11 compo-nents that link the structural descriptors of drugs with specific gene expression responses observed in the three cell lines, and identify structural groups that may be responsible for the responses. Our method quantitatively outperforms the limited earlier studies on CMap and identifies both the previously reported associations and several interesting novel findings, by taking into account multiple cell lines and advanced 3D structural descriptors. The novel observations include: previously unknown similarities in the effects induced by 15-delta prostaglandin J2 and HSP90 inhibitors, which are linked to the 3D descriptors of the drugs; and the induction by simvastatin of leukemia-specific anti-inflammatory response, resem-bling the effects of corticosteroids., Comment: 7 pages, 6 figures

We extend kernelized matrix factorization with a fully Bayesian treatment and with an ability to work with multiple side information sources expressed as different kernels. Kernel functions have been introduced to matrix factorization to integrate side information about the rows and columns (e.g., objects and users in recommender systems), which is necessary for making out-of-matrix (i.e., cold start) predictions. We discuss specifically bipartite graph inference, where the output matrix is binary, but extensions to more general matrices are straightforward. We extend the state of the art in two key aspects: (i) A fully conjugate probabilistic formulation of the kernelized matrix factorization problem enables an efficient variational approximation, whereas fully Bayesian treatments are not computationally feasible in the earlier approaches. (ii) Multiple side information sources are included, treated as different kernels in multiple kernel learning that additionally reveals which side information sources are informative. Our method outperforms alternatives in predicting drug-protein interactions on two data sets. We then show that our framework can also be used for solving multilabel learning problems by considering samples and labels as the two domains where matrix factorization operates on. Our algorithm obtains the lowest Hamming loss values on 10 out of 14 multilabel classification data sets compared to five state-of-the-art multilabel learning algorithms., Comment: Proceedings of the 30th International Conference on Machine Learning (2013)

Detailed and systematic understanding of the biological effects of millions of available compounds on living cells is a significant challenge. As most compounds impact multiple targets and pathways, traditional methods for analyzing structure-function relationships are not comprehensive enough. Therefore more advanced integrative models are needed for predicting biological effects elicited by specific chemical features. As a step towards creating such computational links we developed a data-driven chemical systems biology approach to comprehensively study the relationship of 76 structural 3D-descriptors (VolSurf, chemical space) of 1159 drugs with the gene expression responses (biological space) they elicited in three cancer cell lines. The analysis covering 11350 genes was based on data from the Connectivity Map. We decomposed these biological response profiles into components, each linked to a characteristic chemical descriptor profile. The integrated quantitative analysis of the chemical and biological spaces was more informative about protein-target based drug similarity than either dataset separately. We identified ten major components that link distinct VolSurf features across multiple compounds to specific biological activity types. For example, component 2 (hydrophobic properties) strongly links to DNA damage response, while component 3 (hydrogen bonding) connects to metabolic stress. Individual structural and biological features were often linked to one cell line only, such as leukemia cells (HL-60) specifically responding to cardiac glycosides. In summary, our approach identified specific chemical structures shared across multiple drugs causing distinct biological responses. The decoding of such systematic chemical-biological relationships is necessary to build better models of drug effects, including unidentified types of molecular properties with strong biological effects., Comment: 10 pages, 7 figures, 2 tables

We introduce a factor analysis model that summarizes the dependencies between observed variable groups, instead of dependencies between individual variables as standard factor analysis does. A group may correspond to one view of the same set of objects, one of many data sets tied by co-occurrence, or a set of alternative variables collected from statistics tables to measure one property of interest. We show that by assuming group-wise sparse factors, active in a subset of the sets, the variation can be decomposed into factors explaining relationships between the sets and factors explaining away set-specific variation. We formulate the assumptions in a Bayesian model which provides the factors, and apply the model to two data analysis tasks, in neuroimaging and chemical systems biology., Comment: 9 pages, 5 figures